Caesarstone Ltd. (CSTE) Q1 2026 Earnings Call Prepared Remarks Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The earnings call highlighted several challenges: a significant revenue decline, geopolitical volatility, tariff risks, and ongoing legal proceedings. Despite some positive aspects, such as improved gross margins and a restructuring plan, the market softness in North America and increased expenses overshadow these gains. The Q&A section did not provide clarity or additional insights to mitigate these concerns. Given these factors, the stock is likely to experience a negative reaction in the short term.
Key Financial Performance
Global Revenue $88.7 million, down 14.9% year-over-year on a constant currency basis, primarily reflecting continued softness in global demand and competitive dynamics, mainly in North America.
U.S. Revenue $40 million, down from $49.1 million in the prior year quarter, reflecting persistent market softness and competitive pressures.
Canada Revenue Decreased 23.8% on a constant currency basis due to similar market dynamics as the U.S.
Australia Revenue $17.1 million, up from $13.8 million in the prior year quarter, an increase of approximately 11.2% on a constant currency basis, reflecting the growing acceptance of ICON products in the market.
EMEA Sales Down 10.3% on a constant currency basis, primarily driven by timing of shipments in the indirect distributor channel.
Israel Revenue $4.2 million, down from $5 million in the prior year quarter, mainly due to the impact of the regional conflict.
Gross Margin 22.3%, up from 21.3% in the prior year quarter, an improvement of 100 basis points, reflecting the benefit of an improved production footprint.
Adjusted Gross Margin 23.9%, up from 21.2% in the prior year quarter, reflecting benefits from a more flexible, asset-light production model.
Operating Expenses $39.2 million, representing 44.1% of revenue compared to $35.9 million or 36.1% of revenue in the prior year quarter. The increase is primarily a function of lower revenues.
Adjusted EBITDA Loss of $7.5 million compared to a loss of $7.1 million in the prior year quarter, reflecting relatively stable performance despite lower revenue due to strategic initiatives.
Finance Expense $1.2 million compared to finance income of $2.5 million in the prior year quarter, primarily due to foreign currency exchange rate fluctuations.
Adjusted Diluted Net Loss Per Share $0.32 on 34.6 million shares compared to $0.29 in the prior year quarter on 34.7 million shares.
Net Cash Position $50.4 million as of March 31, 2026, compared to $57.5 million as of December 31, 2025, reflecting restructuring costs and other financial activities.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
Zero Silica ICON Products: Achieved strong revenue growth in Australia, reinforcing brand and innovation alignment with market needs.
Porcelain Products: Continued production at Lioli facility in India, with focus on improving execution and commercial alignment.
North America: Revenue declined due to macroeconomic headwinds and competitive pressures. Targeted actions are being taken to improve channel productivity and strengthen customer relationships.
Australia: Revenue increased by 11.2% year-over-year, marking the third consecutive quarter of growth, driven by the success of ICON products.
EMEA: Sales declined by 10.3% due to shipment timing issues, expected to normalize in the second quarter.
Israel: Revenue impacted by regional conflict, declining to $4.2 million from $5 million in the prior year.
Restructuring Plan: Transitioned quartz production to global manufacturing partner network, achieving cost savings of over $100 million since 2023. Expected annualized savings of $22 million by 2027.
Gross Margin: Improved by 100 basis points to 22.3% despite lower revenues, reflecting benefits of optimized production footprint.
Tariff and Supply Chain Optimization: Implemented price increases in the U.S. to offset higher costs due to tariffs. Actively optimizing supply chain to protect margins.
Restructuring Focus: Evaluating additional cost reduction opportunities, including distribution center consolidation, to reinforce profitability.
ITC Investigation: Assessing potential outcomes of proposed tariff rate quota structure and planning mitigation strategies.
Legislative Advocacy: Monitoring progress of U.S. legislation aimed at limiting liability for silica-related injuries, which could benefit the industry.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Revenue Decline: Global revenue decreased by 15% year-over-year on a constant currency basis, primarily due to macroeconomic headwinds and competitive pressures, particularly in North America.
Geopolitical Volatility: The regional conflict in the Middle East has impacted demand in Israel and increased product costs and sea freights, expected to affect results mainly in the second half of 2026.
Tariff and Trade Policy Risks: The U.S. government has implemented broad-based import tariffs, with an average tariff of 15% on products imported into the U.S. market. Additionally, the ITC investigation may result in further tariff rate quotas and increased costs.
Legal Proceedings: 711 lawsuits alleging silica-related injuries are ongoing, with a $48.8 million provision recorded for probable losses. Insurance coverage disputes and legislative uncertainties add complexity.
Supply Chain Costs: Geopolitical volatility and tariffs have increased product costs and sea freights, impacting the company's margin profile.
Market Softness in North America: Revenue in the U.S. and Canada declined significantly due to persistent market softness and competitive pressures.
Restructuring Costs: Ongoing restructuring activities are expected to incur additional cash costs of $3 million to $5 million for the remainder of 2026.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
Annualized Cash Savings: The company expects to generate annualized cash savings of approximately $22 million by 2027, bringing total savings since 2023 to more than $100 million.
Geopolitical and Tariff Impacts: Geopolitical volatility and increased product costs and sea freights are expected to affect results mainly in the second half of 2026. The U.S. tariff environment, with an average tariff of 15%, is being addressed through supply chain optimization and price increases.
Restructuring Plan: The restructuring plan is expected to yield more than $100 million in annual cash savings by 2027. Additional actions, such as distribution center consolidation and fixed cost reductions, are being evaluated to improve profitability and cash flow.
Adjusted EBITDA: The company remains on track to achieve positive adjusted EBITDA in the third quarter of 2026, assuming no material deterioration in global economic and geopolitical conditions.
Market Recovery and Demand: The company anticipates benefiting from a recovery in countertop demand as consumer confidence and housing market activity normalize.
Australia Market Growth: Australia continues to show strong performance, with the company focusing on strengthening its competitive standing and building on the progress of its ICON products.
ITC Investigation and Tariff Remedies: The ITC has proposed a 4-year tariff rate quota structure with in-quota and out-of-quota tariffs. The company is assessing potential outcomes and plans to mitigate impacts through supply chain optimization and pricing actions.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:Review of Unclear Management Responses
A:
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
Bar Lev
Cray ICR
ICON product
ITC
North America
ad valorem
bill
brand
category
channel
conflict
contribution
demand
distributor
dynamic
freight
import
improvement
injury
manufacturer
manufacturing partner
partner network
period
plan
proceeding
product market
profile
quartz production
quota tariff
recovery
remedy
supply chain
tariff ad
tariff rate
timing
trade
valorem quota
CSTE Transcript
Caesarstone Ltd. (CSTE) Q1 2026 Earnings Call Prepared Remarks Transcript
Unknown5-13
The earnings call highlighted several challenges: a significant revenue decline, geopolitical volatility, tariff risks, and ongoing legal proceedings. Despite some positive aspects, such as improved gross margins and a restructuring plan, the market softness in North America and increased expenses overshadow these gains. The Q&A section did not provide clarity or additional insights to mitigate these concerns. Given these factors, the stock is likely to experience a negative reaction in the short term.
Caesarstone Ltd. (CSTE) Q3 2025 Earnings Call Transcript
Unknown11-12
The earnings call indicates several concerns: declining U.S. and Canadian sales, gross margin decline, and increased operating expenses. The potential tariffs and legal proceedings add uncertainty. Despite some positive developments, such as cost reduction efforts and growth in Australia and EMEA, these do not outweigh the negative impacts. The absence of Q&A also suggests limited analyst engagement or confidence. Overall, the stock is likely to experience a negative reaction due to these factors.
Caesarstone Ltd. (CSTE) Q2 2025 Earnings Call Transcript
Unknown8-7
Despite some positive aspects, such as increased business with Lowe's and a stable EMEA region, the overall sentiment is negative. The earnings call reveals significant challenges, including declining revenues across most regions, gross margin deterioration, and increased litigation risks. The Q&A session confirmed these concerns without providing mitigating factors. Additionally, the impact of new U.S. tariffs and ongoing silicosis-related lawsuits further contribute to a negative outlook. The company's financial health is strained, as evidenced by the adjusted EBITDA loss and increased net loss per share, making a negative stock price reaction likely.
Caesarstone Ltd. (NASDAQ:CSTE) Q4 2024 Earnings Call Transcript
Unknown3-6
The earnings call reveals significant challenges: a substantial revenue decline, missed EPS expectations, and competitive pressures. Despite improved gross margins and cash flow, the lack of a shareholder return plan and substantial silicosis claims pose risks. Management's vague guidance and unchanged negative market dynamics further dampen sentiment. The negative outweighs the positive elements, suggesting a likely negative stock price movement.
CSTE Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
